检索结果 - Andrew S. Garner

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
    Home Visiting and the Biology of Toxic Stress: Opportunities to Address Early Childhood Adversity

    Home Visiting and the Biology of Toxic Stress: Opportunities to Address Early Childhood Adversity 由 Andrew S. Garner

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Preventing Childhood Toxic Stress: Partnering With Families and Communities to Promote Relational Health

    Preventing Childhood Toxic Stress: Partnering With Families and Communities to Promote Relational Health 由 Andrew S. Garner, Michael W. Yogman

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Effects of antiinflammatory agents and prostaglandins on acid and bicarbonate secretions in the amphibian-isolated gastric mucosa

    Effects of antiinflammatory agents and prostaglandins on acid and bicarbonate secretions in the amphibian-isolated gastric mucosa 由 Andrew P. Garner, Gunnar Flemström, Jon R. Heylings

    出版 1979
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations

    Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations 由 Egle Avizienyte, Richard A. Ward, Andrew P. Garner

    出版 2008
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    The Lifelong Effects of Early Childhood Adversity and Toxic Stress

    The Lifelong Effects of Early Childhood Adversity and Toxic Stress 由 Jack P. Shonkoff, Andrew S. Garner, Ben Siegel, Mary I. Dobbins, Marian F. Earls, Andrew S. Garner, Laura McGuinn, John M. Pascoe, David L. Wood

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Acquisition of a single EZH2 D1 domain mutation confers acquired resistance to EZH2-targeted inhibitors

    Acquisition of a single EZH2 D1 domain mutation confers acquired resistance to EZH2-targeted inhibitors 由 Theresa E. Baker, Sujata Nerle, Justin R. Pritchard, Boyang Zhao, Victor M. Rivera, Andrew P. Garner, François Gonzalvez

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Barriers to the Identification and Management of Psychosocial Problems: Changes From 2004 to 2013

    Barriers to the Identification and Management of Psychosocial Problems: Changes From 2004 to 2013 由 Sarah McCue Horwitz, Amy Storfer‐Isser, Bonnie D. Kerker, Moira Szilagyi, Andrew S. Garner, Karen G. O’Connor, Kimberly Hoagwood, Ruth E. K. Stein

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Beyond ADHD: How Well Are We Doing?

    Beyond ADHD: How Well Are We Doing? 由 Ruth E. K. Stein, Amy Storfer‐Isser, Bonnie D. Kerker, Andrew S. Garner, Moira Szilagyi, Kimberly Hoagwood, Karen G. O’Connor, Sarah McCue Horwitz

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Cloning and Characterization of a Novel Human Dual Flavin Reductase

    Cloning and Characterization of a Novel Human Dual Flavin Reductase 由 Mark J. I. Paine, Andrew P. Garner, David J. Powell, Jennifer Sibbald, Mark Sales, Norman Pratt, Trudi S. Smith, David G. Tew, C. Roland Wolf

    出版 2000
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Do Pediatricians Ask About Adverse Childhood Experiences in Pediatric Primary Care?

    Do Pediatricians Ask About Adverse Childhood Experiences in Pediatric Primary Care? 由 Bonnie D. Kerker, Amy Storfer‐Isser, Moira Szilagyi, Ruth E. K. Stein, Andrew S. Garner, Karen G. O’Connor, Kimberly Hoagwood, Sarah McCue Horwitz

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Factors Associated With Whether Pediatricians Inquire About Parents' Adverse Childhood Experiences

    Factors Associated With Whether Pediatricians Inquire About Parents' Adverse Childhood Experiences 由 Moira Szilagyi, Bonnie D. Kerker, Amy Storfer‐Isser, Ruth E. K. Stein, Andrew S. Garner, Karen G. O’Connor, Kimberly Hoagwood, Sarah McCue Horwitz

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Identifying Maternal Depression in Pediatric Primary Care

    Identifying Maternal Depression in Pediatric Primary Care 由 Bonnie D. Kerker, Amy Storfer‐Isser, Ruth E. K. Stein, Andrew S. Garner, Moira Szilagyi, Karen G. O’Connor, Kimberly Hoagwood, Sarah McCue Horwitz

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Ponatinib Inhibits Polyclonal Drug-Resistant KIT Oncoproteins and Shows Therapeutic Potential in Heavily Pretreated Gastrointestinal Stromal Tumor (GIST) Patients

    Ponatinib Inhibits Polyclonal Drug-Resistant KIT Oncoproteins and Shows Therapeutic Potential in Heavily Pretreated Gastrointestinal Stromal Tumor (GIST) Patients 由 Andrew P. Garner, Joseph M. Gozgit, Rana Anjum, Sadanand Vodala, Alexa B. Schrock, Tianjun Zhou, César Serrano, Grant Eilers, Mei‐Jun Zhu, Julia Ketzer, Scott Wardwell, Yaoyu Ning, Youngchul Song, Anna Kohlmann, Frank Wang, Tim Clackson, Michael C. Heinrich, Jonathan A. Fletcher, Sebastian Bauer, Victor M. Rivera

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    An Antibody That Locks HER3 in the Inactive Conformation Inhibits Tumor Growth Driven by HER2 or Neuregulin

    An Antibody That Locks HER3 in the Inactive Conformation Inhibits Tumor Growth Driven by HER2 or Neuregulin 由 Andrew P. Garner, Carl Uli Bialucha, Elizabeth R. Sprague, Joan T. Garrett, Qing Sheng, Sharon Li, Olga Sineshchekova, Parmita Saxena, Cammie R. Sutton, Dongshu Chen, Yan Chen, Huiqin Wang, Jinsheng Liang, Rita Das, Rebecca Mosher, Jian Gu, Alan Huang, Nicole Haubst, Carolin Zehetmeier, Manuela Haberl, Winfried Elis, Christian Künz, Analeah B. Heidt, Kara Herlihy, Joshua Murtie, Alwin G. Schuller, Carlos L. Arteaga, William R. Sellers, Seth A. Ettenberg

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer

    Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer 由 Meredith S. Eno, Jason D. Brubaker, John E. Campbell, Chris De Savi, Timothy J. Guzi, Brett D. Williams, Douglas Wilson, Kevin Wilson, Natasja Brooijmans, Joseph Kim, Ayşegül Özen, Emanuele Perola, John Hsieh, Victoria E. Brown, Kristina M. Fetalvero, Andrew P. Garner, Zhuo Zhang, Faith Stevison, Rich Woessner, Jatinder Singh, Yoav Timsit, Caitlin Kinkema, Clare Medendorp, Christopher S. Lee, Faris Albayya, Alena Zalutskaya, Stefanie S. Schalm, Thomas A. Dineen

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: